Literature DB >> 26235980

The paracrine effect of mesenchymal human stem cells restored hearing in β-tubulin induced autoimmune sensorineural hearing loss.

T J Yoo1, Xiaoping Du2, Bin Zhou3.   

Abstract

The aim of this study was to examine the activities of hASCs (Human Adipose tissue Derived Stem Cells) on experimental autoimmune hearing loss (EAHL) and how human stem cells regenerated mouse cochlea cells. We have restored hearing in 19 years old white female with autoimmune hearing loss with autologous adipose tissue derived stem cells and we wish to understand the mechanism of restoration of hearing in animal model. BALB/c mice underwent to develop EAHL; mice with EAHL were given hASCs intraperitoneally once a week for 6 consecutive weeks. ABR were examined over time. The helper type 1 autoreactive responses and T-reg cells were examined. H&E staining or immunostaining with APC conjugated anti-HLA-ABC antibody were conducted. The organ of Corti, stria vascularis, spira ligament and spiral ganglion in stem cell group are normal. In control group, without receiving stem cells, the organ of Corti is replaced by a single layer of cells, atrophy of stria vascularis. Systemic infusion of hASCs significantly improved hearing function and protected hair cells in established EAHL. The hASCs decreased the proliferation of antigen specific Th1/Th17 cells and induced the production of anti-inflammatory cytokine interleukin10 in splenocytes. They also induced the generation of antigen specific CD4(+)CD25(+)Foxp3(+)T-reg cells. The experiment showed the restoration is due to the paracrine activities of human stem cells, since there are newly regenerated mice spiral ganglion cells, not human mesenchymal stem cells derived tissue given by intraperitoneally.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Autoimmune hearing loss; Paracrine activity; Stem cell therapy

Mesh:

Substances:

Year:  2015        PMID: 26235980     DOI: 10.1016/j.heares.2015.07.021

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  8 in total

Review 1.  Therapeutic Application of Mesenchymal Stem Cells for Cochlear Regeneration.

Authors:  Nagarajan Maharajan; Gwang Won Cho; Chul Ho Jang
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

Review 2.  Inner Ear Drug Delivery for Sensorineural Hearing Loss: Current Challenges and Opportunities.

Authors:  Sophie S Liu; Rong Yang
Journal:  Front Neurosci       Date:  2022-05-24       Impact factor: 5.152

3.  Mesenchymal stem cells for sensorineural hearing loss: a systematic review of preclinical studies.

Authors:  Kevin Chorath; Matthew Willis; Nicolas Morton-Gonzaba; Alvaro Moreira
Journal:  Mol Biol Rep       Date:  2020-04-22       Impact factor: 2.316

Review 4.  Autoimmune Inner Ear Disease: Immune Biomarkers, Audiovestibular Aspects, and Therapeutic Modalities of Cogan's Syndrome.

Authors:  Oded Shamriz; Yuval Tal; Menachem Gross
Journal:  J Immunol Res       Date:  2018-04-23       Impact factor: 4.818

5.  Screening of genes associated with inflammatory responses in the endolymphatic sac reveals underlying mechanisms for autoimmune inner ear diseases.

Authors:  Juhong Zhang; Na Wang; Anting Xu
Journal:  Exp Ther Med       Date:  2018-07-19       Impact factor: 2.447

6.  Cell Transplantation to Restore Lost Auditory Nerve Function is a Realistic Clinical Opportunity.

Authors:  Tetsuji Sekiya; Matthew C Holley
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

7.  Interleukin-10 Contributes to Therapeutic Effect of Mesenchymal Stem Cells for Acute Liver Failure via Signal Transducer and Activator of Transcription 3 Signaling Pathway.

Authors:  Hu-Cheng Ma; Xin Wang; Min-Na Wu; Xin Zhao; Xian-Wen Yuan; Xiao-Lei Shi
Journal:  Chin Med J (Engl)       Date:  2016-04-20       Impact factor: 2.628

Review 8.  Application of Mesenchymal Stem Cell Therapy and Inner Ear Regeneration for Hearing Loss: A Review.

Authors:  Sho Kanzaki; Masashi Toyoda; Akihiro Umezawa; Kaoru Ogawa
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.